A detailed history of Close Asset Management LTD transactions in Amgen Inc stock. As of the latest transaction made, Close Asset Management LTD holds 3,317 shares of AMGN stock, worth $871,210. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,317
Previous 3,317 -0.0%
Holding current value
$871,210
Previous $1.04 Million 3.09%
% of portfolio
0.03%
Previous 0.04%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$268.87 - $324.56 $83,349 - $100,613
-310 Reduced 8.55%
3,317 $943,000
Q4 2023

Feb 08, 2024

SELL
$255.7 - $288.46 $7,671 - $8,653
-30 Reduced 0.82%
3,627 $1.05 Million
Q3 2023

Oct 11, 2023

SELL
$218.65 - $271.46 $54,662 - $67,865
-250 Reduced 6.4%
3,657 $983,000
Q1 2023

Apr 19, 2023

SELL
$225.79 - $275.2 $24,836 - $30,272
-110 Reduced 2.74%
3,907 $945,000
Q2 2022

Jul 29, 2022

SELL
$230.71 - $256.74 $397,974 - $442,876
-1,725 Reduced 30.04%
4,017 $978,000
Q4 2021

Jan 27, 2022

SELL
$198.88 - $227.6 $56,680 - $64,866
-285 Reduced 4.73%
5,742 $1.29 Million
Q1 2021

May 07, 2021

SELL
$221.91 - $258.6 $310,674 - $362,040
-1,400 Reduced 18.85%
6,027 $1.5 Million
Q3 2020

Oct 30, 2020

SELL
$234.65 - $260.95 $148,064 - $164,659
-631 Reduced 7.83%
7,427 $1.89 Million
Q2 2020

Jul 28, 2020

SELL
$197.81 - $242.74 $7,912 - $9,709
-40 Reduced 0.49%
8,058 $1.9 Million
Q3 2019

Nov 06, 2019

SELL
$174.11 - $208.62 $10,446 - $12,517
-60 Reduced 0.74%
8,098 $1.57 Million
Q2 2019

Aug 01, 2019

BUY
$166.7 - $195.41 $106,021 - $124,280
636 Added 8.46%
8,158 $1.5 Million
Q1 2019

May 10, 2019

BUY
$180.87 - $203.88 $1.34 Million - $1.51 Million
7,422 Added 7422.0%
7,522 $1.43 Million
Q4 2018

Jan 28, 2019

SELL
$178.4 - $208.25 $1.38 Million - $1.61 Million
-7,742 Reduced 98.72%
100 $4,000
Q1 2018

May 11, 2018

BUY
$169.43 - $198.0 $37,274 - $43,560
220 Added 2.89%
7,842 $1.3 Million
Q4 2017

Feb 13, 2018

SELL
$168.79 - $188.59 $28,694 - $32,060
-170 Reduced 2.18%
7,622 $1.33 Million
Q3 2017

Feb 13, 2018

BUY
$167.29 - $191.0 $588,860 - $672,320
3,520 Added 82.4%
7,792 $0
Q3 2017

Nov 14, 2017

SELL
$167.29 - $191.0 $588,860 - $672,320
-3,520 Reduced 45.17%
4,272 $796,000
Q2 2017

Feb 13, 2018

BUY
N/A
3,520 Added 82.4%
7,792 $1.34 Million
Q2 2017

Nov 14, 2017

SELL
N/A
-3,520 Reduced 45.17%
4,272 $0
Q1 2017

Feb 13, 2018

BUY
N/A
3,520 Added 82.4%
7,792 $1.28 Million
Q1 2017

Nov 14, 2017

SELL
N/A
-650 Reduced 13.21%
4,272 $701,000
Q4 2016

Nov 14, 2017

BUY
N/A
4,922
4,922 $720,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $140B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Close Asset Management LTD Portfolio

Follow Close Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Close Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Close Asset Management LTD with notifications on news.